B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics
Blast crisis (BC) is one of the most dreaded complications of chronic myeloid leukemia (CML). Fortunately, the incidence of BC has diminished markedly in the <i>BCR-ABL</i> tyrosine kinase inhibitor (TKI) era. The primary objective of initial treatment in BC is to achieve a second chroni...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-10-01
|
| Series: | International Journal of Molecular Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1422-0067/23/19/11836 |